Medical management of acute myocardial infarction was associated with a significantly higher rate of 90-day all-cause readmission compared to percutaneous coronary intervention (30.5% vs 15.4%).
Observational (n=96,546)
Yes
Does percutaneous coronary intervention reduce 90-day post-discharge healthcare costs and utilization compared to medical management in Medicare beneficiaries with acute myocardial infarction?
While total 90-day costs are similar between PCI and medical management for AMI, medical management incurs significantly higher post-discharge costs and readmission rates, highlighting the need to account for heterogeneous post-discharge care in bundled payment models.
Absolute Event Rate: 30.5% vs 15.4%
p-value: p=<0.0001
OBJECTIVES: Evaluate the cost of illness associated with the 90-day period following acute myocardial infarction (AMI) and the implication of care pathway (percutaneous coronary intervention PCI vs medical management MM), in order to assess the potential financial risk incurred by providers for AMI as an episode of care. PERSPECTIVE: Reimbursement payment systems for acute care episodes are shifting from 30-day to 90-day bundled payment models. Since follow-up care and readmissions beyond the early days/weeks post-AMI are common, financial risk may be transferred to providers. SETTING: AMI hospitalization Centers for Medicare & Medicaid Services (CMS) standard analytical files between 10/1/2015 and 9/30/2016 were reviewed. METHODS: Included patients were Medicare beneficiaries with a primary diagnosis of AMI subsequently treated with either PCI or MM. Payments were standardized to remove geographic variation and separated into reimbursements for services during the hospitalization and from discharge to 90 days post-discharge. Results were stratified by Medicare Severity Diagnosis Related Groups (MS-DRGs) individually and grouped between patients treated with MM and PCI. Risk-adjusted likelihood of utilization of post-acute nursing care and all-cause readmission was assessed by logistic regression. RESULTS: A total of 96, 546 patients were included in the analysis. The highest total mean payment (US32, 714) was for MS-DRG 248 (PCI with non-drug-eluting stent with major complication or comorbidity). Total payments were similar between MM and PCI patients, but MM patients incurred the majority of costs in the post-acute period after discharge, with the converse true for PCI patients. MM without catheterization was associated with a twofold increase in risk of requiring post-acute nursing care and 90-day readmission versus PCI (odds ratio 95% confidence interval: 2. 01 1. 92-2. 11 and 2. 17 2. 08-2. 27). Smaller hospital size, diabetes, peripheral arterial disease, prior AMI, and multivessel disease were predictors of higher healthcare utilization. CONCLUSIONS: MS-DRGs associated with the lowest reimbursements (and presumably, lowest costs of inpatient care) incur the highest post-discharge expenditures. As the CMS Bundled Payment for Care Improvement and similar programs are implemented, there will be a need to account for heterogeneous post-discharge care costs. Video abstract (MP4 274659 KB).
Allen et al. (Mon,) conducted a observational in Acute Myocardial Infarction (n=96,546). Medical management vs. Percutaneous coronary intervention (PCI) was evaluated on 90-day all-cause readmission (p=<0.0001). Medical management of acute myocardial infarction was associated with a significantly higher rate of 90-day all-cause readmission compared to percutaneous coronary intervention (30.5% vs 15.4%).